Long-term Remote Ischemic Preconditioning Improve Long-term Prognosis of Acute Myocardial Infarction Patients Without Emergency Reperfusion Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02843464|
Recruitment Status : Unknown
Verified July 2016 by Xuanwu Hospital, Beijing.
Recruitment status was: Not yet recruiting
First Posted : July 25, 2016
Last Update Posted : January 12, 2017
|Condition or disease||Intervention/treatment||Phase|
|Myocardial Infarction||Other: reported remote ischemic preconditioning (RIPC)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||220 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||December 2016|
|Estimated Primary Completion Date :||July 2018|
Experimental: long-term RIPC group
routine treatment + once RIPC/day for a year. Three five-minute cycles of upper limb ischaemia and three five-minute pauses using a blood pressure cuff inflated to 200 mmHg.
Other: reported remote ischemic preconditioning (RIPC)
Three five-minute cycles of upper limb ischaemia and three five-minute pauses using a blood pressure cuff inflated to 200 mmHg.
No Intervention: control group
- The major adverse cardiovascular events (MACE) include cardiovascular death, spontaneous myocardial infarction, unplanned revascularization and stroke. [ Time Frame: one year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02843464
|Contact: Zhi Liu, firstname.lastname@example.org|